Biomolecule-releasing adhesive to help repair the shoulder labrum
Official title: Biomolecule releasing adhesive for cell-mediated labral repair
Funded at University of Texas Arlington · NIH-11348900 · Data updated 2026-11-12
A new adhesive material released from biomolecules aims to help healing of injured shoulder labrum tissue in patients who need labral repair.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $398,391 |
| NIH project number | 5R01AR081979-04 |
| Project ID | NIH-11348900 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with glenoid labrum tears undergoing repair or those at risk of poor healing may benefit from this approach.
✕Less likely to help
Patients not needing labral repair or with contraindications to the adhesive or biomaterial components may not benefit.
What this research studies
If you have a shoulder labral tear, this project explores a biomolecule-releasing adhesive that could promote healing of the labrum after repair. Researchers will test how the adhesive behaves in a lab setting and in animal models to understand how it supports tissue regeneration and anchors to the shoulder joint. The goal is to move beyond standard sutures and provide a treatment that enhances natural repair and reduces persistent pain or instability. The work focuses on understanding the biology of labral healing and developing a material that can assist recovery after surgery.
Why it matters
Potential benefit: If successful, patients could experience stronger labrum healing and better shoulder stability after repair.
How similar studies have gone: Related tissue-healing approaches have shown promise, but applying a biomolecule-releasing adhesive to the labrum is a newer strategy.
Where this research is happening
-
University of Texas Arlington
Arlington, United States Active
Researchers
- Principal investigator: Tang, Liping — University of Texas Arlington
- Study coordinator: Tang, Liping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.